In addition, the variant (rs7529229) of the IL-6 receptor, which increases the level of circulating IL-6 and lowers the concentration of C-reactive protein and fibrinogen, reduced the risk of coronary heart disease events [97]. This evidence concerns the gene CRP and coronary artery disorder.